Developing drugs faster using the next generation of cell-free and microbial protein manufacturing methods
South San Francisco, CA
Joined June 2020
- Tweets14
- Following75
- Followers99
- Likes17
Pinned Tweet
genengnews.com/on-your-radar…
An article about our work to accelerate treatments for COVID-19 was recently published in GEN!
SwiftScale Biologics retweeted
@AlixVentures has an excellent write-up covering the past and future of CFPS. Highlights @SwiftScaleBio and @SutroBio.
medium.com/bios-community/fr….
SwiftScale Biologics retweeted
Founder Spotlight: David Mace @ SwiftScale Biologics, a biotechnology company that enables fast protein synthesis via cell-free technology 💊🚀
medium.com/bios-community/fo…
SwiftScale Biologics retweeted
Featured by @INVOatNU for @NUSynbio developments of #cellfree biomanufacturing with @mattdelisa and @SwiftScaleBio. invo.northwestern.edu/techno…
Cheers to our academic co-founder! Well deserved
Elected #NAI Fellow. I am so grateful for colleagues, mentors, collaborators, and students. Thank you!
@NUSynBio @NorthwesternU @NorthwesternEng @INVOatNU @StemloopInc @SwiftScaleBio
SwiftScale Biologics retweeted
Really good thread. Answer: cell free, in vitro transcription!
This quoted post is unavailable.
SwiftScale Biologics retweeted
#ABPDUCanHelpYou support the fight against #COVID19.
We worked with @SwiftScaleBio and @casprbio to ramp up production of COVID-19 treatments and diagnostics. ow.ly/P9oH50BWKei
Interested in working with us? Contact us ➡️ ow.ly/COqd50BWKeh
SwiftScale Biologics retweeted
Those guys are great for production. Can't wait to see them grow. @SwiftScaleBio
SwiftScale Biologics retweeted
It's beyond time to moved past animal-derived antibody production. It's slow, expensive, and cruel.
Would love to support a team building in vitro technologies for antibody generation.
Who's working on this?
nature.com/articles/s41587-0…
SwiftScale Biologics retweeted
Typically, once antibodies are engineered, pharmaceutical companies must spend another 9+ months to optimize the manufacture and scaleup of these therapies. @SwiftScaleBio' cell-free technology cuts scale-up down to a single month. bit.ly/2G7wLKX #synbiobeta2020
We are looking for a Site Head of Quality Assurance to join our team at SwiftScale. If you have experience in biopharmaceutical QA and want to help get more life-saving therapeutics get in the clinic more quickly please apply!
linkedin.com/jobs/view/20048…
SwiftScale Biologics retweeted
The #ABPDU is helping two #biotech companies—@casprbio & @SwiftScaleBio—scale-up production of potential diagnostics and treatments for #COVID19. Watch 🎥 ⬇️ to learn more. #BioBSE @BerkeleyLab #NatLabsInTheFight youtu.be/FOfhMvtNZzM
SwiftScale Biologics retweeted
@NorthwesternEng Prof. Michael Jewett | Going “Cell Free” Can Put a Rush on COVID-19 Antibody Therapies genengnews.com/on-your-radar… via @GENbio @NUSynBio @jewettlab_NU @SwiftScaleBio
SwiftScale Biologics retweeted
@SwiftScaleBio has created an #antibody development and #manufacturing platform that incorporates #cell free #technology.
This technology could put a rush on #covid19 antibody #therapies.
#SupportingScience
#BakerScience
Learn more:
bit.ly/33hJeEZ
